Brain Disease Modalities And Software Market Size, Share, Trend, Scope Report 2026 to 2035
Brain disease modalities and software Market Segments:
Global Brain disease modalities and software Market by Products
- Brain analysis software
- Brain imaging modalities
Global Brain disease modalities and software Market by Type of Patients
- Adults
- Paediatrics
- Infants
Global Brain disease modalities and software Market by End-User
- Hospitals and clinics
- Ambulatory surgery centers
- Diagnostic imaging centers
Global Brain disease modalities and software Market by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
North America
- U.S.
- Canada
Europe
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Australia & New Zealand
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Landscape
- Company Overview
- Financial Performance
- Key Development
- Latest Strategic Developments
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Brain disease modalities and software Market Snapshot
Chapter 4. Global Brain disease modalities and software Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Products Estimates & Trend Analysis
5.1. By Products & Market Share, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Products:
5.2.1. Brain analysis software
5.2.1.1. PET Devices
5.2.1.2. CT Devices
5.2.1.3. MRI Devices
5.2.1.4. PET-CT
5.2.1.5. PET-MRI
5.2.2. Brain imaging modalities
Chapter 6. Market Segmentation 2: By Type of Patients Estimates & Trend Analysis
6.1. By Products & Market Share, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Type of Patients:
6.2.1. Adults
6.2.2. Pediatrics
6.2.3. Infants
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. By Products & Market Share, 2025 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By End User:
7.2.1. Hospitals and clinics
7.2.2. Ambulatory surgery centers
7.2.3. Diagnostic imaging centers
Chapter 8. Brain disease modalities and software Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By Products, 2022 - 2035
8.1.2. North America Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By Type of Patients, 2022 - 2035
8.1.3. North America Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By End User, 2022 - 2035
8.1.4. North America Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts by country, 2022 - 2035
8.1.4.1. U.S.
8.1.4.2. Canada
8.2. Europe
8.2.1. Europe Brain disease modalities and software Market revenue (US$ Million) By Products, 2022 - 2035
8.2.2. Europe Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By Type of Patients, 2022 - 2035
8.2.3. Europe Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By End User 2022 - 2035
8.2.4. Europe Brain disease modalities and software Market revenue (US$ Million) by country, 2022 - 2035
8.2.4.1. Germany
8.2.4.2. Poland
8.2.4.3. France
8.2.4.4. Italy
8.2.4.5. Spain
8.2.4.6. UK
8.2.4.7. Rest of Europe
8.3. Asia Pacific
8.3.1. Asia Pacific Brain disease modalities and software Market revenue (US$ Million) By Products, 2022 - 2035
8.3.2. Asia Pacific Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By Type of Patients, 2022 - 2035
8.3.3. Asia Pacific Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By End User, 2022 - 2035
8.3.4. Asia Pacific Brain disease modalities and software Market revenue (US$ Million) by country, 2022 - 2035
8.3.4.1. China
8.3.4.2. India
8.3.4.3. Japan
8.3.4.4. Australia
8.3.4.5. Rest of Asia Pacific
8.4. Latin America
8.4.1. Latin America Brain disease modalities and software Market revenue (US$ Million) By Products, 2022 - 2035
8.4.2. Latin America Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By Type of Patients, 2022 - 2035
8.4.3. Latin America Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By End User, 2022 - 2035
8.4.4. Latin America Brain disease modalities and software Market revenue (US$ Million) by country, (US$ Million) 2022 - 2035
8.4.4.1. Brazil
8.4.4.2. Rest of Latin America
8.5. Middle East & Africa
8.5.1. Middle East & Africa Brain disease modalities and software Market revenue (US$ Million) By Products, (US$ Million)
8.5.2. Middle East & Africa Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By Type of Patients, 2022 - 2035
8.5.3. Middle East & Africa Brain disease modalities and software Market revenue (US$ Million) estimates and forecasts By End User, 2022 - 2035
8.5.4. Middle East & Africa Brain disease modalities and software Market revenue (US$ Million) by country, (US$ Million) 2022 - 2035South Africa
8.5.4.1. GCC Countries
8.5.4.2. Rest of MEA
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Quantib
9.2.2. Brainomix
9.2.3. Qure.AI
9.2.4. General Electric Company
9.2.5. Imaging Biometrics, LLC
9.2.6. United Imaging Healthcare Co. Ltd.
9.2.7. Siemens
9.2.8. Healthineers AG
9.2.9. Koninklijke Philips N.V.
9.2.10. Canon Inc.
9.2.11. Vuno Co. Ltd.
9.2.12. Aspect Imaging
9.2.13. IXICO
9.2.14. QMENTA
9.2.15. Cortechs.ai
9.2.16. A.I. Analysis Inc.
9.2.17. Fujifilm Holdings Corporation
9.2.18. Other Prominent Players.
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Brain Disease Modalities And Software Market Size is valued at USD 15.2 Billion in 2025 and is predicted to reach USD 25.66 Billion by the year 2035.
Brain disease modalities and software Market expected to grow at a 5.5% CAGR during the forecast period for 2026-2035.
United Imaging Healthcare, Koninklijke Philips N.V., General Electric Company, Canon Inc., Siemens Healthineers AG, Vuno Co., Ltd., Fujifilm Holdings
Brain disease modalities and software market are segmented into Hospitals and Clinics, Ambulatory Surgery Centers, Diagnostic Imaging Centers.
North America region is leading the Brain disease modalities and software Market.